Persistent non-visible haematuria with albuminuric chronic kidney disease — MSRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Refer for nephrology assessment and arrange renal ultrasound, without a suspected cancer pathway referral at present
This man has persistent invisible haematuria, confirmed by at least 2 positive reagent-strip tests from 3 samples. His ACR of 76 mg/mmol is a marker of kidney damage and does not require confirmation because it is at least 70 mg/mmol. In the context of persistence over more than 3 months, this establishes CKD despite a preserved eGFR. NICE recommends nephrology referral for CKD with ACR of 70 mg/mmol or more. NICE also recommends renal ultrasound for adults with CKD and visible or persistent invisible haematuria. A suspected cancer pathway is not indicated solely from this presentation: unexplained non-visible haematuria requires age 60 years or over plus dysuria or a raised white cell count for bladder cancer referral. He is 53, has neither feature, and has no visible haematuria. Repeating the ACR would be appropriate for a result between 3 and 70 mg/mmol, but not at 76 mg/mmol. Annual surveillance alone is appropriate for persistent isolated invisible haematuria without proteinuria, not for marked albuminuria. CT urography and routine urology referral are not the indicated first pathway here.
Reference: NICE NG203: Chronic kidney disease: assessment and management — Recommendations (2021) — https://www.nice.org.uk/guidance/ng203/chapter/Recommendations NICE NG12: Suspected cancer: recognition and referral — Recommendations organised by site of cancer (2015, updated 2026) — https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer